abstracts

0

Page précédente

Abstracts Strasbourg 2004

Type présentation Jour(s) N° Session Auteurs Titre Adresses
Poster 26-28   23  P083 N Simon (1); E Sampol (1); J Albanese (2); M Leone (2); C Martin (2); P Arvis (3); B Lacarelle (1); B Bruguerolle (1); Population Pharmacokinetics of moxifloxacin in plasma and bronchial secretions in patients with severe bronchopneumonia 
Abstract complet
(1) Departement de Pharmacologie, CHU Timone, Marseille; (2) Département d’Anesthésie, CHU Nord, Marseille; (3) Medical Affairs Department, Bayer, Puteaux;
Poster 26-28   23  P084 A Prémaud (1); J Debord (1); A Rousseau (1); JC Szelag (2); Y Le Meur (2); P Marquet (1); Evaluation of the predictive performance of Bayesian forecasting for mycophenolic acid AUC estimation in renal transplant recipients 
Abstract complet
(1) Pharmacologie et Toxicologie, CHU de Limoges, Limoges; (2) Népphrologie – Hémodialyse, CHU de Limoges, Limoges;
Poster 26-28   23  P085 E Krupka (1); N Venisse (2); C Lafay (1); D Gendre (1); B Diquet (3); S Bouquet (in Memoriam) (2); MC Perault (1); Probe of CYP3A by a single-point blood measurement after oral administration of midazolam in healthy elderly volunteers 
Abstract complet
(1) Service de Pharmacologie Clinique, Centre de Recherche Clinique, CHU Poitiers, Poitiers; (2) Laboratoire de Pharmacocinétique, CHU Poitiers, Poitiers; (3) Service de Pharmacologie et Toxicologie, CHRU, Angers;
Poster 26-28   23  P086 N Simon (1); A Boulamery (1); S Arguillere (2); F Viallet (2); O Blin (1); B Bruguerolle (1); Pharmacokinetic and pharmacodynamic analysis of levodopa in parkinsonian patients with dyskinesia 
Abstract complet
(1) Service de Pharmacologie Médicale et Clinique, Faculté de Médecine de Marseille, Marseille; (2) Service de Neurologie, C.H. du Pays d’Aix, Aix en Provence;
Poster 26-28   23  P087 B Guillet (1); C Botta (2); R Purgus (3); Y Berland (3); P Pisano (1); Total and free mycophénolic acid (MPA) plasma levels in renal transplant patients with chronic graft dysfunction 
Abstract complet
(1) Laboratoire de Pharmacodynamie, Faculté de Pharmacie, Marseille; (2) Laboratoire de Pharmacocinétique, Hôpital La Timone, Marseille; (3) Service de Néphrologie, Hopital La Concenption, Marseille;
Poster 26-28   23  P088 E Mannaert (1); P Bouhours (2); JC Levron (2); Pharmacokinetic profile of long-acting injectable risperidone at steady-state, comparison with oral administration 
Abstract complet
(1) Pharmaceutical Research and Development, Johnson & Johnson, Beerse, Belgium; (2) Medical Affairs Neurosciences, Janssen-Cilag, Issy les Moulineaux;
Poster 26-28   23  P089 A Al Ahmad (1); R Andriantsitohaina (1); G Ubeaud (1); Transport of flavonoids across human intestinal epithelial and vascular endothelial cells 
Abstract complet
(1) UMR CNRS 7034, Faculté de Pharmacie, Illkirch;
Poster 26-28   23  P090 A Tran (1); C Giraud (2); E Rey (2); J Vincent (3); JM Tréluyer (2); G Pons (2); Clobazam metabolism by CDNA-expressed human cyp, influence of CYP2C19 genotype 
Abstract complet
(1) Pharmacologie, Ecole Pratique des Hautes Etudes, Paris; (2) Pharmacologie, Hôp. Saint-Vincent de Paul,Université R.Descartes, Paris; (3) Laboratoires Biocodex, Montrouge;
Poster 26-28   23  P091 L Coulbault (1); M Beaussier (2); C Verstuyft (1); H Weickmans (2); P Jaillon (1); A Lienhardt (2); L Becquemont (1); Impact of UDP-Glucuronosyltransférase 2B7 genetic polymorphism on morphine metabolism among patients 
Abstract complet
(1) Service de Pharmacologie, Université Pierre et Marie Curie, Paris VI, Paris; (2) Anesthésie Réanimation, Hôpital Saint-Antoine, Paris;
Poster 26-28   23  P092 S Mouly (1); C Verstuyft (2); G Simoneau (1); N Rizzo-Padoin (3); A Knellwolf (1); L Becquemont (4); JF Bergmann (1); Do the MDR1 and/or CYP3A5 genetic polymorphisms predict the Erythromycin Breath Test (14C-ERMBT) in HIV patients treated with HAART ? 
Abstract complet
(1) Unité de Recherche Thérapeutiques, Service de Médecine InterneA, AP-HP Hôpital Lariboisière, Paris; (2) Service de Pharmacologie, Université Pierre et Marie Curie, Paris VI, Paris; (3) Service de Biophysique et Médecine Nucléaire, AP-HP Hôpital Lariboisière, Paris; (4) Service de Pharmacologie, Université Bicêtre, Paris XI, Kremlin Bicêtre;
Poster 26-28   23  P093 N Matt (1); NB Ghyselinck (1); V Dupe (1); O Wendling (1); P Chambon (1); M Mark (1); Pharmacological and genetic approches to investigate retinoic acid signalling pathways in mouse embryos 
Abstract complet
(1) IGBMC, CNRS, Illkirch;

Page précédente